SELLAS Life Sciences (SLS) Other Non-Current Liabilities (2011 - 2022)

SELLAS Life Sciences (SLS) has 12 years of Other Non-Current Liabilities data on file, last reported at $170000.0 in Q3 2022.

• On a quarterly basis, Other Non-Current Liabilities fell 96.62% year-over-year to $170000.0 in Q3 2022; TTM through Sep 2022 was $170000.0, a 96.62% decrease from a year earlier, with the FY2021 full-year figure at $296000.0, down 93.61% from the prior year.
• Other Non-Current Liabilities for Q3 2022 stood at $170000.0, down from $181000.0 in the prior quarter.
• Over the last five years, Other Non-Current Liabilities for SLS reached as high as $5.3 million in Q3 2018 and fell as low as $170000.0 in Q3 2022.
• Historically, Other Non-Current Liabilities has averaged $3.9 million across 5 years, with a median of $4.8 million in 2019.
• Across the five-year window, Other Non-Current Liabilities jumped 320.29% in 2018 and slumped 96.62% in 2022, its largest moves.
• Year by year, Other Non-Current Liabilities stood at $4.3 million in 2018, then grew by 13.55% to $4.9 million in 2019, then decreased by 5.68% to $4.6 million in 2020, then slumped by 93.61% to $296000.0 in 2021, then slumped by 42.57% to $170000.0 in 2022.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $170000.0 in Q3 2022, $181000.0 in Q2 2022, and $296000.0 in Q1 2022.